Generation of transgenic fibroblasts producing doxycycline-inducible human interferon-α or erythropoietin for a bovine mammary bioreactor

Molecular Medicine Reports
Hee Young KangEui-Bae Jeung

Abstract

Interferon α (IFN-α) is a cytokine, produced predominantly in immune cells in response to pathogens, which interferes with viral replication in host cells. Another cytokine hormone, erythropoietin (EPO), is synthesized in interstitial fibroblasts of the kidney and acts as a stimulator for the production of red blood cells. Importantly, the two cytokines have been used in the treatment of certain hematological malignancies, including renal anemia. In the production of recombinant proteins, a transgenic expression system in bovine species is an efficient strategy for pharmaceutical production. In the present study, recombinant constructs capable of producing recombinant human IFN-α and EPO proteins were established and were generated containing the mammary gland-specific αS1-casein promoter region (between -175 and + 796 nt), as this promoter was revealed to have the highest level of activity in a previous promoter study. In order to minimize developmental toxicity by constitutive exogenous expression, a doxycycline (dox)-inducible system was introduced to the IFN-α/EPO-expressing constructs. Therefore, a unitary tetracycline (tet)-on the IFN-α/EPO vector was established, which combined a tet-on activator cassette controlled by t...Continue Reading

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M Gossen, H Bujard
Sep 1, 1991·Bio/technology·P KrimpenfortR Strijker
Jan 1, 1986·Annals of the New York Academy of Sciences·J M RosenL Y Yu-Lee
Mar 1, 1995·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·F Belardelli
Oct 6, 1997·Journal of Dairy Science·R J WallK R Bondioli
May 20, 1999·Nature Biotechnology·A BaguisiY Echelard
Jun 8, 1999·Annual Review of Immunology·C A BironT P Salazar-Mather
Aug 17, 1999·Annual Review of Nutrition·J M RosenD Hadsell
Oct 6, 1999·Current Opinion in Biotechnology·F Baneyx
Nov 5, 1999·Nature Medicine·S GallucciP Matzinger
Dec 28, 1999·Reproduction, Fertility, and Development·K A Zuelke
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·C KubotaX Yang
Jul 19, 2000·Current Opinion in Immunology·C Bogdan
Jan 27, 2007·European Journal of Haematology·Wolfgang Jelkmann
Jul 28, 2007·Critical Reviews in Oncology/hematology·Vivien M HodgesA Peter Maxwell
Aug 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xiangzhong Yang, Mark G Carter
Feb 24, 2009·Advances in Chronic Kidney Disease·Iain C Macdougall, Michael Ashenden
Nov 17, 2010·The Journal of Physiology·Wolfgang Jelkmann

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.